BMJ7h
POS0107 IDENTIFICATION OF POTENTIAL GENES AND TREATMENT RESPONSE TO TOFACITINIB THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
3 Institute for Medical Research, National Institutes of Health Complex, Allergy and Immunology Research Center, Selangor Darul Ehsan, Malaysia 4 Hospital Selayang, Department of Medicine, Selangor ...
BMJ23h
Association of circulating CXCL10 and CXCL11 with systemic sclerosis
Correspondence to Professor Clara Crescioli, Department of Movement, Human and Health Sciences, Section of Health Sciences, Università degli Studi di Roma “Foro Italico”, Rome 00135, Italy; ...
BMJ1d
Not only synovitis but also tenosynovitis needs to be considered: why it is time to update textbook images of rheumatoid arthritis
Correspondence to Professor Annette van der Helm-van Mil, Rheumatology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands; A.H.M.van_der_Helm{at}lumc.nl Rheumatoid arthritis (RA) is ...
BMJ2d
PPARγ preservation via promoter demethylation alleviates osteoarthritis in mice
Objectives Osteoarthritis (OA) is the most common degenerative joint disease in aged population and its development is significantly influenced by aberrant epigenetic modifications of numerous OA ...
BMJ3d
Vascularised human skin equivalents as a novel in vitro model of skin fibrosis and platform for testing of antifibrotic drugs
Correspondence to Dr Jörg H W Distler, Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, ...
BMJ3d
Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures
The Lupus Research Unit, The Rayne Institute, Lambeth Wing, St Thomas’ Hospital, London, UK Correspondence to: Dr D P D’Cruz The Lupus Research Unit, The Rayne Institute, St Thomas’ Hospital, London ...
BMJ3d
Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses
Objective Immune complexes (ICs) play a critical role in the pathology of autoimmune diseases. The aim of this study was to generate and characterise a first-in-class anti-FcγRIIA antibody (Ab) ...
BMJ4d
Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study
Objective To investigate the rate of serious bacterial, viral or opportunistic infection in patients with rheumatoid arthritis (RA) starting tocilizumab (TCZ) versus tumour necrosis factor inhibitors ...
BMJ4d
POS0894 ANTI-IL-6 THERAPY EFFECT FOR REFRACTORY JOINT AND SKIN INVOLVEMENT IN SYSTEMIC SCLEROSIS: A REAL-WORLD, SINGLE CENTER EXPERIENCE
Background: Emerging evidence during the last two decades supports a pivotal role of Interleukin 6 (IL-6) in the pathogenesis of Systemic Sclerosis (SSc). Standard immunosuppressive agents are often ...
BMJ5d
Vitamin D receptors in the rheumatoid lesion: expression by chondrocytes, macrophages, and synoviocytes
University Department of Medicine, Manchester Royal Infirmary, Oxford Road, Manchester, M13 9WL Dr D E Woolley. METHODS Immunolocalisation techniques using a rat monoclonal antibody to VDR and an ...
BMJ5d
SAT0026 Survival and Mortality Rates in Lupus Nephritis Patients
Background Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease, characterized by multisystemic organ involvement and with a broad spectrum of clinical and laboratory manifestations.
BMJ5d
Synovial macrophage M1 polarisation exacerbates experimental osteoarthritis partially through R-spondin-2
Correspondence to Professor Daozhang Cai and Dr Xiaochun Bai, Department of Orthopedics, Academy of Orthopedics - Guangdong Province, Orthopedic Hospital of Guangdong Province, The Third Affiliated ...